Reinoso-Arija, RocíoLópez-Ramírez, CeciliaJimenez-Ruiz, José AntonioLópez-Campos, José Luis2022-08-262022-08-262021-09-18Reinoso-Arija R, López-Ramírez C, Jimenez-Ruiz JA, López-Campos JL. Effectiveness of aprepitant in post-acute COVID19 syndrome. Clin Case Rep. 2021 Sep 18;9(9):e04646http://hdl.handle.net/10668/3958This is the first case of a patient taking aprepitant for a post-acute COVID-19 syndrome. This case may encourage researchers to look for the evidence for the efficacy and safety of a neurokinin 1 receptor antagonist in this frequent syndrome.enAtribución-NoComercial 4.0 InternacionalAtribución-NoComercial 4.0 Internacionalhttp://creativecommons.org/licenses/by-nc/4.0/AprepitantPost-acuteCOVID19SARS-CoV-2Atención subagudaInfecciones por coronavirusSíndromeSaludMedical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Neurotransmitter Agents::Neurokinin-1 Receptor AntagonistsMedical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::HumansMedical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Signs and Symptoms::Signs and Symptoms, Digestive::NauseaMedical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Signs and Symptoms::Signs and Symptoms, Digestive::VomitingMedical Subject Headings::Persons::Persons::Age Groups::AdultMedical Subject Headings::Diseases::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus InfectionsMedical Subject Headings::Health Care::Environment and Public Health::Public Health::Disease Outbreaks::Epidemics::PandemicsMedical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Pathologic Processes::InflammationMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Clinical Laboratory Techniques::Immunologic Tests::Serologic TestsEffectiveness of aprepitant in post-acute COVID19 syndromeresearch article34567551open access10.1002/ccr3.46462050-0904PMC8449093